Tenofovir therapy is associated with increased urinary phosphate excretion and decreased bone mineral density in patients with chronic hepatitis B

被引：0
|
作者：
Le, S. [1 ,2 ]
Wong, P. [3 ,4 ,5 ]
Shochet, I. [6 ]
Doyle, A. [1 ]
Shelton, E. [1 ]
Milat, F. [3 ,4 ,5 ]
Sievert, W. [1 ,2 ]
机构：
[1] Monash Hlth, Dept Gastroenterol & Hepatol, Clayton, Vic 3168, Australia
[2] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Monash Hlth, Dept Endocrinol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Med, Southern Clin Sch, Clayton, Vic 3168, Australia
[6] Monash Hlth, Dept Gen Med, Clayton, Vic 3168, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [41] Tenofovir use may be associated with increased risk of loss of bone mineral density from spine but not from hip
    Das, S.
    Bopitya, S.
    David, L.
    HIV MEDICINE, 2012, 13 : 48 - 48
  • [42] RELATIVELY DECREASED RISK OF HEPATOCELLULAR CARCINOMA RECURRENCE DURING TENOFOVIR TREATMENT IN CHRONIC HEPATITIS B PATIENTS
    Kawaguchi, Kazunori
    Honda, Masao
    Shimode, Tetsuhiro
    Orita, Noriaki
    Nio, Kouki
    Terashima, Takeshi
    Shimakami, Tetsuro
    Arai, Kuniaki
    Yamashita, Taro
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    HEPATOLOGY, 2021, 74 : 492A - 492A
  • [43] Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures
    Yu Jin Kim
    Dong Hyun Sinn
    Geum-Youn Gwak
    Moon Seok Choi
    Kwang Cheol Koh
    Seung Woon Paik
    Byung Chul Yoo
    Joon Hyeok Lee
    World Journal of Gastroenterology, 2012, (47) : 6996 - 7002
  • [44] Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy
    Bruera, D
    Luna, N
    David, DO
    Bergoglio, LA
    Zamudio, J
    AIDS, 2003, 17 (13) : 1917 - 1923
  • [45] Fibrosis in patients with chronic hepatitis B and minimally raised ALT during tenofovir therapy
    Jeng, Wen-Juei
    Chien, Rong-Nan
    Liaw, Yun-Fan
    LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 910 - 911
  • [46] Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome
    Pan, Bo-Lin
    Loke, Song-Seng
    PLOS ONE, 2018, 13 (01):
  • [47] Serum cytokine profiles and chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
    Lou, Chunmin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (02) : 295 - 296
  • [48] Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures
    Kim, Yu Jin
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Choi, Moon Seok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    Lee, Joon Hyeok
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (47) : 6996 - 7002
  • [49] URINARY FREE CORTISOL EXCRETION AS A MARKER OF DECREASED BONE DENSITY IN PATIENTS WITH ADRENAL CUSHING'S SYNDROME
    Takiguchi, Miwa Kimura
    Morimoto, Satoshi
    Watanabe, Daisuke
    Abe, Koichiro
    Ichihara, Atsuhiro
    JOURNAL OF HYPERTENSION, 2023, 41 : E398 - E398
  • [50] Clinical Impact of Hepatic Steatosis in Patients with Chronic Hepatitis B Infection on Tenofovir Therapy
    Song, JeonqEun
    Lee, Hye Won
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Park, Jun Yong
    HEPATOLOGY, 2016, 64 : 936A - 937A
12345